Food and Drug Administration
Endocrinologic & Metabolic Drugs Advisory Committee
September 25, 2002
Briefing Information
Clinical Trials for New Osteoporosis Treatments
Guidelines for Preclinical and Clinical Evaluation of Agents Used in the Prevention and Treatment of Postmenopausal Osteoporosis pdf